CD276 and neuroblastoma: Alternatively, GPC2/CD276 BiCisCAR T cells displayed effective killing activity against GPC2-KO or CD276-KO NB cells, except when both targets were knocked out in IMR32 cells (Supplemental Figure 7, G and H–J).